Why we're lowering our Bristol Myers price target despite an earnings beat, guidance raise

Source: CNBC | Published: April 24, 2025, 5:45 p.m.

Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.

Read Original Article Back to News List

Related News

Trump Organization sells 'Trump 2028' hat and shirt, fueling questions about third term bid

3 hours, 1 minute ago

Alphabet expects 'slight headwind' to ads business this year, executives say

3 hours, 9 minutes ago

The trade war's wave of retail shortages will hit U.S. consumers in stages. Here's when

3 hours, 39 minutes ago

Jim Cramer credits this week's rally to earnings and restraint from the White House

3 hours, 57 minutes ago

Intel CFO says tariffs increase chance for economic slowdown, recession getting likelier

4 hours, 17 minutes ago